These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38331407)

  • 1. Cardiac MRI in diagnosis, prognosis, and follow-up of hypertrophic cardiomyopathy in children: current perspectives.
    Spaapen TOM; Bohte AE; Slieker MG; Grotenhuis HB
    Br J Radiol; 2024 May; 97(1157):875-881. PubMed ID: 38331407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):13. PubMed ID: 22296938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial tissue characterization by gadolinium-enhanced cardiac magnetic resonance imaging for risk stratification of adverse events in hypertrophic cardiomyopathy.
    Raiker N; Vullaganti S; Collins JD; Allen BD; Choudhury L
    Int J Cardiovasc Imaging; 2020 Jun; 36(6):1147-1156. PubMed ID: 32166506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
    Axelsson Raja A; Farhad H; Valente AM; Couce JP; Jefferies JL; Bundgaard H; Zahka K; Lever H; Murphy AM; Ashley E; Day SM; Sherrid MV; Shi L; Bluemke DA; Canter CE; Colan SD; Ho CY
    Circulation; 2018 Aug; 138(8):782-792. PubMed ID: 29622585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular magnetic resonance predictors of heart failure in hypertrophic cardiomyopathy: the role of myocardial replacement fibrosis and the microcirculation.
    Raphael CE; Mitchell F; Kanaganayagam GS; Liew AC; Di Pietro E; Vieira MS; Kanapeckaite L; Newsome S; Gregson J; Owen R; Hsu LY; Vassiliou V; Cooper R; Mrcp AA; Ismail TF; Wong B; Sun K; Gatehouse P; Firmin D; Cook S; Frenneaux M; Arai A; O'Hanlon R; Pennell DJ; Prasad SK
    J Cardiovasc Magn Reson; 2021 Mar; 23(1):26. PubMed ID: 33685501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of cardiac magnetic resonance-based markers in patients with hypertrophic cardiomyopathy.
    Dohy Z; Szabo L; Toth A; Czimbalmos C; Horvath R; Horvath V; Suhai FI; Geller L; Merkely B; Vago H
    Int J Cardiovasc Imaging; 2021 Jun; 37(6):2027-2036. PubMed ID: 33555536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Cardiac Magnetic Resonance Feature Tracking (CMR-FT) Analysis for Detection of Myocardial Fibrosis in Pediatric Hypertrophic Cardiomyopathy.
    Bogarapu S; Puchalski MD; Everitt MD; Williams RV; Weng HY; Menon SC
    Pediatr Cardiol; 2016 Apr; 37(4):663-73. PubMed ID: 26833321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy: Current state of the art.
    Kamal MU; Riaz IB; Janardhanan R
    Cardiol J; 2016; 23(3):250-63. PubMed ID: 27064795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.
    Weng Z; Yao J; Chan RH; He J; Yang X; Zhou Y; He Y
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1392-1402. PubMed ID: 27450876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progression of myocardial fibrosis in hypertrophic cardiomyopathy: mechanisms and clinical implications.
    Raman B; Ariga R; Spartera M; Sivalokanathan S; Chan K; Dass S; Petersen SE; Daniels MJ; Francis J; Smillie R; Lewandowski AJ; Ohuma EO; Rodgers C; Kramer CM; Mahmod M; Watkins H; Neubauer S
    Eur Heart J Cardiovasc Imaging; 2019 Feb; 20(2):157-167. PubMed ID: 30358845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
    J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial fibrosis progression on cardiac magnetic resonance in hypertrophic cardiomyopathy.
    Choi HM; Kim KH; Lee JM; Yoon YE; Lee SP; Park EA; Lee W; Kim YJ; Cho GY; Sohn DW; Kim HK
    Heart; 2015 Jun; 101(11):870-6. PubMed ID: 25897040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy].
    Maron MS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Dec; 37(12):1057-63. PubMed ID: 20193172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Cardiac MRI in the Diagnosis and Risk Stratification of Hypertrophic Cardiomyopathy.
    Rowin EJ; Maron MS
    Arrhythm Electrophysiol Rev; 2016; 5(3):197-202. PubMed ID: 28116085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of late gadolinium enhancement on cardiac magnetic resonance in patients with hypertrophic cardiomyopathy.
    He D; Ye M; Zhang L; Jiang B
    Heart Lung; 2018; 47(2):122-126. PubMed ID: 29174363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside.
    Bogaert J; Olivotto I
    Radiology; 2014 Nov; 273(2):329-48. PubMed ID: 25340269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Role of the Progression of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy.
    Aquaro GD; Todiere G; Barison A; Grigoratos C; Parisella ML; Adami M; Grilli G; Pagura L; Faggioni L; Cioni D; Lencioni R; Emdin M; Neri E
    Am J Cardiol; 2024 Jan; 211():199-208. PubMed ID: 37949342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.